Japan's Takeda has entered into a new manufacturing partnership with Hyderabad-based Biological E. Limited (BE) in India to boost production capacity for its dengue fever vaccine Qdenga. This collaboration aims to accelerate access to Qdenga and brings Takeda closer to its goal of producing 100 million doses of the vaccine...
Schwarzkopf’s Color Caravan Tours India
Schwarzkopf, the hair care brand owned by Henkel, a German multinational, has embarked on a marketing initiative that they call the "Color Caravan." This traveling activation aims to encourage consumers across India to try out Schwarzkopf's extensive range of hair color products. The Color Caravan will visit various cities throughout...
India’s Lupin Acquires German Diabetes Drug Rights
Mumbai-based Lupin Ltd acquired brands Ondero and Ondero-Met from drug maker Boehringer Ingelheim International GmbH, Germany. This also includes the acquisition of trademark rights associated with these brands. According to Lupin, an estimated 77 million people above the age of 18 years in India have Type-2 Diabetes, while nearly 25...
Germany’s Prejex Inc., Partners India’s Polybond for Needle-less Injections
Prejex Inc., a spin-off of Germany-based Prejex GMBH, entered into an agreement with Pune India-based Polybond, of the Rathi Group, to manufacture needle-less injections. This partnership has enabled the shifting of the manufacturing capabilities of the German company from Berlin to Pune. The Prejex-Polybond factory will make needle-less injections for...
U.S., India, 16 Allies Strengthen Supply Chains
U.S. Secretary of State Antony Blinken and Commerce Secretary Gina Raimondo co-hosted the Supply Chain Ministerial Forum virtually on July 19-20. A partnership was formed of 18 economies: the U.S. EU, Australia, Brazil, Canada, Congo, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, South Korea, Singapore, Spain and the U.K....
Germany Approves Bharat Biotech’s COVAXIN for Travel
German Ambassador to India and Bhutan, Walter J Lindner, announced that the government of Germany recognized WHO-listed Bharat Biotech's Covid vaccine, COVAXIN, for travel to the country starting June 1. In November last year the World Health Organization issued an emergency use listing for Covaxin, adding to a growing portfolio...